Discover open access scientific publications

Search, annotate, share and cite publications

Publications by B.E. Miller

Hematologic Toxicity on RTOG 0418: A Phase II Study of Post-Operative IMRT for Gynecologic Cancer

International Journal of Radiation Oncology Biology Physics

English

Updated 4-Year Results for NRG Oncology/Rtog 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer

International Journal of Radiation Oncology Biology Physics

English

Related publications

A Phase II Study of Acute Toxicity for Celebrex™ (Celecoxib) and Chemoradiation in Patients With Locally Advanced Cervical Cancer: Primary Endpoint Analysis of RTOG 0128

International Journal of Radiation Oncology Biology Physics

English

Toxicity and Biochemical Outcomes of Dose-Intensified Post-Operative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial

International Journal of Radiation Oncology Biology Physics

English

A Study on Post-Operative Wound Infections

International Journal of Current Microbiology and Applied Sciences

2018

English

Intensity Modulated Radiation Therapy (IMRT) for Craniospinal Irradiation (CSI) on Helical Tomotherapy (HT): Effect of Low-Dose Bath on Acute Hematologic Toxicity

International Journal of Radiation Oncology Biology Physics

English

(P044) Toxicity of Post-Operative Intensity Modulated Radiation Therapy in Patients With Cervical Cancer

International Journal of Radiation Oncology Biology Physics

English

Phase II Trial of Nab-Paclitaxel in the Treatment of Recurrent or Persistent Advanced Cervix Cancer: A Gynecologic Oncology Group Study

English

Proposal of a Post-Prostatectomy Clinical Target Volume Based on Pre-Operative MRI: Volumetric and Dosimetric Comparison to the RTOG Guidelines

English

A Phase II Multicenter Trial of Concurrent Chemoradiotherapy With Weekly Nedaplatin in Advanced Uterine Cervical Carcinoma: Tohoku Gynecologic Cancer Unit Study

English

A Phase II Study of Once a Day Partial Breast Irradiation (PBI) for Early-Stage or Noninvasive Breast Cancer: Early Toxicity Outcomes

International Journal of Radiation Oncology Biology Physics

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by B.E. Miller

Hematologic Toxicity on RTOG 0418: A Phase II Study of Post-Operative IMRT for Gynecologic Cancer

Updated 4-Year Results for NRG Oncology/Rtog 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer

Related publications

A Phase II Study of Acute Toxicity for Celebrex™ (Celecoxib) and Chemoradiation in Patients With Locally Advanced Cervical Cancer: Primary Endpoint Analysis of RTOG 0128

Toxicity and Biochemical Outcomes of Dose-Intensified Post-Operative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial

A Study on Post-Operative Wound Infections

Intensity Modulated Radiation Therapy (IMRT) for Craniospinal Irradiation (CSI) on Helical Tomotherapy (HT): Effect of Low-Dose Bath on Acute Hematologic Toxicity

(P044) Toxicity of Post-Operative Intensity Modulated Radiation Therapy in Patients With Cervical Cancer

Phase II Trial of Nab-Paclitaxel in the Treatment of Recurrent or Persistent Advanced Cervix Cancer: A Gynecologic Oncology Group Study

Proposal of a Post-Prostatectomy Clinical Target Volume Based on Pre-Operative MRI: Volumetric and Dosimetric Comparison to the RTOG Guidelines

A Phase II Multicenter Trial of Concurrent Chemoradiotherapy With Weekly Nedaplatin in Advanced Uterine Cervical Carcinoma: Tohoku Gynecologic Cancer Unit Study

A Phase II Study of Once a Day Partial Breast Irradiation (PBI) for Early-Stage or Noninvasive Breast Cancer: Early Toxicity Outcomes